EUCRATES BIOMEDICAL ACQU COR - *W EXP 10/23/202 (EUCRW)

CUSIP: G3141W122

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / *W EXP 10/23/202
Total 13F shares
1,337,052
Share change
-30,995
Total reported value
$385,719
Price per share
$0.04
Number of holders
14
Value change
-$1,819
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP G3141W122?
CUSIP G3141W122 identifies EUCRW - EUCRATES BIOMEDICAL ACQU COR - *W EXP 10/23/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EUCRATES BIOMEDICAL ACQU COR - *W EXP 10/23/202 (EUCRW) as of Q3 2022

As of 30 Sep 2022, EUCRATES BIOMEDICAL ACQU COR - *W EXP 10/23/202 (EUCRW) was held by 14 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,337,052 shares. The largest 10 holders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), 683 Capital Management, LLC, Altium Capital Management LP, Granite Point Capital Management, L.P., Magnetar Financial LLC, COWEN AND COMPANY, LLC, Arena Investors LP, AQR Arbitrage LLC, Radcliffe Capital Management, L.P., and JANE STREET GROUP, LLC. This page lists 14 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.